Mark Hasleton

Mark Hasleton

Algemeen Directeur bij
ProTA Therapeutics Pty Ltd.
54 jaar
Health Technology
Consumer Services

Profiel

Mark Hasleton currently works at Prota Therapeutics Pty Ltd., as Chief Executive Officer.
Dr. Hasleton also formerly worked at Teva Pharmaceutical Industries Ltd., as Senior Director-Global New Therapeutic Entities from 2010 to 2018, Bristol Myers Squibb Co., as Manager-EMEA Business Operations, and Oramed Pharmaceuticals, Inc., as Vice President-Business Development from 2018 to 2019.
Dr. Hasleton received his doctorate degree from Imperial College London, graduate degree from The University of Manchester, and Masters Business Admin degree from Imperial College Business School.

Actieve functies van Mark Hasleton

BedrijvenFunctieBegin
Algemeen Directeur -

Eerdere bekende functies van Mark Hasleton

BedrijvenFunctieEinde
ORAMED PHARMACEUTICALS INC. Corporate Officer/Principal 27-08-2019
TEVA PHARMACEUTICAL INDUSTRIES LIMITED Corporate Officer/Principal 01-01-2018
BRISTOL-MYERS SQUIBB COMPANY Corporate Officer/Principal -
Ervaring van Mark Hasleton in detail bekijken

Opleiding van Mark Hasleton

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

77

Eerstegraads connecties

7

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit7

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Consumer Services

Health Technology

  1. Beurs
  2. Insiders
  3. Mark Hasleton